Back to top
more

Hologic (HOLX)

(Delayed Data from NSDQ)

$67.81 USD

67.81
4,294,477

-0.25 (-0.37%)

Updated Aug 15, 2025 04:00 PM ET

After-Market: $67.84 +0.03 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (151 out of 246)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Hologic (HOLX) Gains But Lags Market: What You Should Know

by Zacks Equity Research

Hologic (HOLX) closed the most recent trading day at $76.28, moving +1.46% from the previous trading session.

Zacks Equity Research

Hologic (HOLX) Crossed Above the 20-Day Moving Average: What That Means for Investors

by Zacks Equity Research

Should investors be excited or worried when a stock crosses above the 20-day simple moving average?

Zacks Equity Research

Here's How Much You'd Have If You Invested $1000 in Hologic a Decade Ago

by Zacks Equity Research

Holding on to popular or trending stocks for the long-term can make your portfolio a winner.

Zacks Equity Research

Why Hologic (HOLX) is Poised to Beat Earnings Estimates Again

by Zacks Equity Research

Hologic (HOLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

Is Trending Stock Hologic, Inc. (HOLX) a Buy Now?

by Zacks Equity Research

Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks Equity Research

Hologic (HOLX) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Hologic (HOLX) closed at $78.34 in the latest trading session, marking a +0.88% move from the prior day.

Zacks Equity Research

HOLX vs. EW: Which Stock Is the Better Value Option?

by Zacks Equity Research

HOLX vs. EW: Which Stock Is the Better Value Option?

Zacks Equity Research

Pulse Biosciences, Inc (PLSE) Reports Q4 Loss, Lags Revenue Estimates

by Zacks Equity Research

Pulse Biosciences, Inc (PLSE) delivered earnings and revenue surprises of 22% and 6.22%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Here's Why You Should Retain Hologic (HOLX) Stock for Now

by Zacks Equity Research

Investors are optimistic about Hologic's (HOLX) robust international performance and strength in its GYN Surgical business.

Zacks Equity Research

Hologic (HOLX) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Hologic (HOLX) closed the most recent trading day at $76.67, moving +0.99% from the previous trading session.

Zacks Equity Research

Is Most-Watched Stock Hologic, Inc. (HOLX) Worth Betting on Now?

by Zacks Equity Research

Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks Equity Research

Hologic (HOLX) Gains But Lags Market: What You Should Know

by Zacks Equity Research

Hologic (HOLX) closed the most recent trading day at $75.19, moving +0.2% from the previous trading session.

Zacks Equity Research

TransMedics (TMDX) Soars 9.9%: Is Further Upside Left in the Stock?

by Zacks Equity Research

TransMedics (TMDX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks Equity Research

Hologic (HOLX) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Hologic (HOLX) closed the most recent trading day at $74.91, moving +1.37% from the previous trading session.

Zacks Equity Research

Can Value Investors Select Hologic (HOLX) Stock Now?

by Zacks Equity Research

Is Hologic (HOLX) a great pick from the value investor's perspective right now? Read on to know more.

Zacks Equity Research

Hologic (HOLX) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

Hologic (HOLX) closed the most recent trading day at $70.28, moving -1.24% from the previous trading session.

Zacks Equity Research

Why Is Hologic (HOLX) Down 3.4% Since Last Earnings Report?

by Zacks Equity Research

Hologic (HOLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Hologic (HOLX) Stock Moves -0.14%: What You Should Know

by Zacks Equity Research

Hologic (HOLX) closed the most recent trading day at $70.90, moving -0.14% from the previous trading session.

Zacks Equity Research

Here's Why You Should Retain Hologic (HOLX) Stock for Now

by Zacks Equity Research

Investors are optimistic about Hologic's (HOLX) impressive Breast Imaging and Interventional Breast Solutions business performance.

Zacks Equity Research

Hologic (HOLX) Q1 Earnings Surpass Estimates, Margins Down

by Zacks Equity Research

Impressive performance by Hologic's (HOLX) Breast Imaging and Interventional Breast Solutions drove Q1 revenues.

Zacks Equity Research

Hologic (HOLX) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Hologic (HOLX) delivered earnings and revenue surprises of 80.83% and 31.43%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Riya Anand headshot

Medical Products Stock Earnings on Feb 2: BSX, TMO & More

by Riya Anand

Medical Products companies' Q4 results are likely to reflect an increase in COVID-19 testing demand. Let's see how BSX, TMO, HOLX and MCK are poised ahead of their earnings releases.

Zacks Equity Research

Quest Diagnostics (DGX) COVID Test Sales Aid Amid Price Woe

by Zacks Equity Research

Quest Diagnostics' (DGX) base business continues to improve, signifying the ongoing recovery trend of the industry.

Zacks Equity Research

Diagnostics Sales to Drive Hologic's (HOLX) Q1 Earnings

by Zacks Equity Research

Strength in the Diagnostics division is likely to have contributed to Hologic's (HOLX) fiscal first-quarter revenues.

Zacks Equity Research

NextGen's (NXGN) Integrated Platform to Enhance Tribal Health

by Zacks Equity Research

NextGen's (NXGN) integrated platform was adopted by a community health center in Northern California to meet the health requirements of American Indians/Alaska Natives.